PSS39 Assessment of the Health Status Using the 12-Item Medical Outcomes Study Short Form (SF-12) Questionnaire (2578 Dermatological Out-Patients) (original) (raw)

ranged between €9.44 (UK) and €121.17 (Sweden); mean direct non-medical costs were Յ€2.85/episode. Indirect costs contributed significantly to the total cost/episode in Italy (81.4%; €91.14), UK (79.8%; €37.55), Germany (60.0%; €26.74) and Sweden (59.5%; €182.07), whereas indirect costs contributed only 14.7% (€3.54) in Spain, where the value associated with absence from work/school was low. CONCLUSIONS: AOM was associated with substantial economic burden in these European countries. The cost per episode and the contribution of direct/indirect costs varied between countries, potentially reflecting socioeconomic differences and variation in AOM management.